Tevogen TVGN
NASDAQ TVGN
$7.29 -0.05 (-0.68%)
At close: Sep 10, 2026 · 4:00 PM EDT

Tevogen (TVGN) Total Current Liabilities (2021 - 2026)

Tevogen's (TVGN) quarterly Total Current Liabilities came in at $7.3 million in Q1 2026, down 16.64% on a YoY basis from $8.7 million in Q1 2025, and up 2.83% quarter-over-quarter from $7.1 million in Q4 2025.

Analysis

Tevogen (TVGN) Total Current Liabilities (2021 - 2026) Analysis & Trends

Tevogen (TVGN) has reported Total Current Liabilities for 6 consecutive years, with $7.3 million the latest figure, recorded in Q1 2026.

  • For the quarter ending Q1 2026, Total Current Liabilities fell 16.64% year-over-year to $7.3 million; the trailing twelve-month figure through Mar 2026 stood at $7.3 million (down 16.64% YoY), and the FY2025 full-year result was $7.1 million, down 21.83% from the prior year.
  • Total Current Liabilities grew to $7.3 million in Q1 2026 per TVGN's latest filing, from $7.1 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $85.5 million in Q4 2023 and bottomed at $178999.0 in Q1 2022.
  • Historically, Total Current Liabilities has averaged $9.8 million across 5 years, with a median of $7.1 million in 2025.
  • The sharpest annual moves came in 2023 and 2024: Total Current Liabilities soared 24291.09% in 2023, then plunged 89.42% in 2024.
  • Over 5 years, Total Current Liabilities stood at $350454.0 in 2022, then jumped by 24291.09% to $85.5 million in 2023, then slumped by 89.42% to $9.0 million in 2024, then slipped by 21.83% to $7.1 million in 2025, then gained by 2.83% to $7.3 million in 2026.
  • According to Business Quant data, Total Current Liabilities over the past three periods registered $7.3 million, $7.1 million, and $6.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Krystal Biotech 10.21 Bn 9.37 Bn 112.79 Mn 127.40 Mn
2 CRISPR Therapeutics AG 5.04 Bn 5.04 Bn - 132.90 Mn
3 Iovance Biotherapeutics 3.65 Bn 3.36 Bn 55.72 Mn 106.85 Mn
4 Legend Biotech 3.54 Bn 2.57 Bn 251.50 Mn 403.60 Mn
5 uniQure 2.95 Bn 2.95 Bn 5.49 Mn 83.35 Mn
6 Beam Therapeutics 2.55 Bn 2.55 Bn - 80.88 Mn
7 Precigen 2.39 Bn 2.39 Bn 52.17 Mn 29.35 Mn
8 Sarepta Therapeutics 2.16 Bn 1.37 Bn 251.87 Mn 502.91 Mn
9 Vericel 1.93 Bn 1.77 Bn 56.40 Mn 52.53 Mn
10 Tevogen 27.76 Mn 27.76 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 7.27 Mn
Dec 31, 2025 7.07 Mn
Sep 30, 2025 6.74 Mn
Jun 30, 2025 8.08 Mn
Mar 31, 2025 8.72 Mn
Dec 31, 2024 9.04 Mn
Sep 30, 2024 10.42 Mn
Jun 30, 2024 10.61 Mn
Mar 31, 2024 8.94 Mn
Dec 31, 2023 85.48 Mn
Sep 30, 2023 1.83 Mn
Jun 30, 2023 1.52 Mn
Mar 31, 2023 667,074.00
Dec 31, 2022 350,454.00
Sep 30, 2022 281,783.00
Jun 30, 2022 259,234.00
Mar 31, 2022 178,999.00
Dec 31, 2021 59,375.00